show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Methotrexate

Previous Next

Most Commonly Used

Methotrexate 50mg/2ml for Inj
Drug Image
Methotrexate 2.5mg Tab
Roxane Laboratories Inc
Pill Identification: 54 323 
Drug Image
Methotrexate 2.5mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: M 14 
Drug Image
Methotrexate 50mg/2ml for Inj
Drug Image
Methotrexate 50mg/2ml for Inj
Drug Image

Also See:

  • Answers to Frequently-Asked Questions (FAQs)
  • Other Class Related Drugs
  • Additional Patient Usage Statistics


Overview Information on Methotrexate Sodium

Pharmacist Tip
Tell your dentist or doctor that you are taking methotrexate before you have a surgical procedure.     
Methotrexate is a medicine that comes from folic acid and is called an antimetabolite. Methotrexate is given to patients to treat a number of medical conditions, including a skin condition called psoriasis. It is also given to patients to treat rheumatoid arthritis and certain types of cancers.

When used to treat cancer, methotrexate works by interfering with the growth of cancer cells, as well as stopping new cancer cells from being made. Methotrexate is given alone but sometimes in combination with other cancer medicines to treat breast, lung, and head and neck cancers, and certain lymphomas.



Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013
Methotrexate is a medicine that comes from folic acid and is called an antimetabolite. Methotrexate is given to patients to treat a number of medical conditions, including a skin condition called psoriasis. It is also given to patients to treat rheumatoid arthritis and certain types of cancers.

When used to treat cancer, methotrexate works by interfering with the growth of cancer cells, as well as stopping new cancer cells from being made. Methotrexate is given alone but sometimes in combination with other cancer medicines to treat breast, lung, and head and neck cancers, and certain lymphomas.



Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013